Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 263-158-1 | CAS number: 61790-67-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 14 December 2015 to 20 January 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- The LLNA is the study of choice for skin sensitisation. As detailed in the OECD 429 guideline, despite the advantages of the LLNA, it should be recognised that there are certain limitations that may necessitate the use of TG 406. Chemical groups such as metal salts, organometal, unsaturated compounds and surfactants have been known to be linked to false positive. The Substance is considered to be amphiphilic in nature and therefore would likely have surfactant characteristics, which are known to be falsely positive in the LLNA. Therefore a Guinea Pig Study, OECD 406, was selected to decrease the uncertainty of possible falsely positive effects.
Test material
- Reference substance name:
- Fatty acids, tallow, compds. with triethanolamine
- EC Number:
- 263-158-1
- EC Name:
- Fatty acids, tallow, compds. with triethanolamine
- Cas Number:
- 61790-67-8
- IUPAC Name:
- Fatty acids, tallow, esters of triethanolamine
- Test material form:
- liquid
- Details on test material:
- Appearance: Brown liquid
Storage: At ambient temperature, protected from light
1
- Specific details on test material used for the study:
- TREATMENT OF TEST MATERIAL PRIOR TO TESTING
For the purpose of the study, the test item was prepared immediately prior to dosing in liquid paraffin for the topical applications (pre-test). This vehicle was chosen as it produced the most suitable formulation at the required concentration. Indeed, the preparation of the test item at 50 % in liquid paraffin (w/w) was a yellow solution.
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Age at study initiation: 2 or 3 weeks old.
- Weight at study initiation: Between 242 g and 268 g.
- Housing: The animals were housed individually or in groups of two in polycarbonate cages. The flooring of the cages was covered with dust-free wood shavings and the top fitted a stainless steel lid containing a feeding device and drinking device of 500 mL.
- Diet: Ad libitum
- Water: Ad libitum
- Acclimation period: Minimum acclimatization period of 5 days under housing and diet conditions identical to those of the test.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 °C ± 3 °C
- Humidity (%): from 30 % to 70 %
- Air changes (per hr): At least 10 cycles per hour
- Photoperiod (hrs dark / hrs light): Circadian cycle (12 hrs day/ 12 hrs darkness)
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- paraffin oil
- Concentration / amount:
- 100 % in liquid paraffin
- Day(s)/duration:
- 6 hours
- Adequacy of induction:
- highest technically applicable concentration used
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 100% test item
- Day(s)/duration:
- 6 hours
- Adequacy of induction:
- highest technically applicable concentration used
Challengeopen allclose all
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- paraffin oil
- Concentration / amount:
- 100 % in liquid paraffin
- Day(s)/duration:
- 6 hours
- Adequacy of challenge:
- highest non-irritant concentration
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 100% test item
- Day(s)/duration:
- 6 hours
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- Control group: 10 animals
Test material group: 20 animals - Details on study design:
- MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 3 local applications
- Exposure period: 6 hours under an occlusive dressing (25mm x 50mm non-woven swab of 4-layer patch from MEDISTOCK held in contact with the skin by means of 50 mm wide hypoallergenic micropore™ adhesive tape from 3M and Blenderm™ from 3M).
- Site: The animals were carefully shorn before each test item application on the inter-scapular zone.
- Frequency of applications: Applications were performed on Day 0, Day 7 and Day 14. Animals were then left untreated for 13 days.
- Concentrations: 100 % diluted at 75 %, 50 %, and 25 % (0.5 mL).
- Removal: Washing of the skin after removal of the dressing was done with liquid paraffin.
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Exposure period: 6 hours
- Test groups: On the previously shorn dorso-lumbar zone, an application on either side of the spine, under occlusive dressing (25mm x 50mm non-woven swab of 4-layer patch from MEDISTOCK held in contact with the skin by means of 50 mm wide hypoallergenic micropore™ adhesive tape from 3M and Blenderm™ from 3M).
- Control group: On the previously shorn dorso-lumbar zone, an application on either side of the spine, under occlusive dressing (25mm x 50mm non-woven swab of 4-layer patch from MEDISTOCK held in contact with the skin by means of 50 mm wide hypoallergenic micropore™ adhesive tape from 3M and Blenderm™ from 3M).
- Site: On the previously shorn dorso-lumbar zone on either side of the spine.
- Concentrations: 0.5 mL of the undiluted test material on the left flank and 0.5 mL of liquid paraffin in the right flank.
Removal: Washing of the skin after removal of the dressing was done with liquid paraffin.
- Evaluation (hr after challenge): A macroscopic evaluation of the cutaneous reactions (erythema and oedema) was conducted and all the local or systemic reactions were recorded for animals of the control and treated groups. Approximately 24 hours after removal of the occlusive dressing, the cutaneous reactions were observed and graded according to the scales given below.
- Approximately 24 hours later (i.e. 48 hours after removal of the occlusive dressing), a second observation was made.
Grading scale:
0 No visible change
1 Discrete or patchy erythema
2 Moderate and confluent erythema
3 Intense erythema and swelling
OTHER:
The animals were weighed at the beginning of the study, before the second induction and at the end of the study. - Challenge controls:
- The animals of the control groups were subject to the same experimental procedure as the treatment groups.
- Positive control substance(s):
- no
Results and discussion
- Positive control results:
- alpha-Hexylcinnamaldehyde (CAS: 101-86-0) showed sensitisation at 24 and 48 hours.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 100% liquid paraffin
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none observed
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100 % test item
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- none observed
- Remarks on result:
- no indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100 % test item
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- none observed
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 100% liquid paraffin
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none observed
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 50%
- No. with + reactions:
- 5
- Total no. in group:
- 20
- Clinical observations:
- sensitisation
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 50%
- No. with + reactions:
- 5
- Total no. in group:
- 20
- Clinical observations:
- sensitisation
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 25%
- No. with + reactions:
- 3
- Total no. in group:
- 20
- Clinical observations:
- sensitisation
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 25%
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Clinical observations:
- sensitisation
- Remarks on result:
- positive indication of skin sensitisation
Any other information on results incl. tables
Preliminary study
24 and 48 hours after removal of the patches, no cutaneous reaction was noted at all tested concentrations. In view of these results, the concentration selected was 100 % for the 3 inductions of the main study and the concentration selected was 100 % (MNIC) for the challenge phase.
Main study:
- Induction phase: After the first induction, no cutaneous reaction was noted in the treated group. After the second induction, discrete erythema was noted in seven animals (7 /20) and no cutaneous reaction was noted in the other animals (13/20) of the treated group.
After the third induction, moderate erythema was noted in one animal (1/20), discrete erythema was noted in one animal (1/20), and no cutaneous reaction was noted in the other animals (18/20) of the treated group.
No cutaneous reaction was recorded during the induction phase in the control group.
- Challenge phase: The concentration selected for the induction phase and the challenge was based on the result of the pre-test. Readings were performed 24 and 48 hours after removal of the patches.
In the treated group (treatment concentration of 100 %), no macroscopic cutaneous reactions attributable to allergy were recorded during the examination following the removal of the occlusive dressing (challenge phase).
In the control group (associated with the treatment concentration of 100 %), no cutaneous reaction was observed during the examination following the removal of the occlusive dressing.
In the treated group on the treated area with liquid paraffin, no macroscopic cutaneous reactions attributable to allergy were recorded during the examination following the removal of the occlusive dressing (challenge phase).
No cutaneous reaction was recorded in animals from the control groups after the challenge phase, on the treated area with liquid paraffin (control item).
Weight evolution
No abnormalities and no differences in the body weight between the control and the treated group were observed.
Mortality
No mortality occurred during the main test.
Clinical signs
No abnormal clinical signs related to the administration of the test item were observed.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- The test material was considered to be a non-sensitiser under the conditions of this study in accordance with EU criteria.
- Executive summary:
The potential of the test material to act as a sensitiser was investigated in a GLP study in accordance with the standardised guidelines OECD 406, EU Method B.6 and US EPA OPPTS 870.2600.
After induction of 20 guinea-pigs by 3 topical applications with the test item applied as supplied (100 %) under occlusive dressing and a 13-day rest phase, the challenge phase, under occlusive dressing for 6 hours, consisted to a single topical application of the test item at 100 % and of a negative control (liquid paraffin). The concentration selected for the induction phase and the challenge based on the result of a pre-test. Readings were performed 24 and 48 hours after removal of the patches.
In the treated group (treatment concentration of 100 %), no macroscopic cutaneous reactions attributable to allergy was recorded during the examination following the removal of the occlusive dressing (challenge phase). In the control group (associated with the treatment concentration of 100 %), no cutaneous intolerance reaction was observed during the examination following the removal of the occlusive dressing. In the treated group on the treated area with liquid paraffin, no macroscopic cutaneous reactions attributable to allergy was recorded during the examination following the removal of the occlusive dressing (challenge phase). No cutaneous reaction was recorded in animals from the control groups after the challenge phase, on the treated area with liquid paraffin (control item).
In conclusion, the test material was considered to be a non-sensitiser under the conditions of this study in accordance with EU criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.